Clinical Trials Logo

Clinical Trial Summary

The purpose of the proposed study is to evaluate the effects of administering intravenous tranexamic acid (TXA) to patients undergoing high tibial osteotomy (HTO) and tibial tubercle osteotomy (TTO) to minimize hemarthrosis within the knee joint and post operative pain and swelling.


Clinical Trial Description

Not Provided ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03606109
Study type Interventional
Source NYU Langone Health
Contact
Status Completed
Phase Phase 4
Start date June 26, 2018
Completion date June 2, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05759039 - SHould You transFer the Tubercle? N/A